Biotechnology
The Biotechnology industry has a total of 614 stocks, with a combined market cap of $1.07 trillion and total revenue of $105.61 billion.
Market Cap
1.07T
Revenue
105.61B
Profits
-42.19B
PE Ratio
n/a
Profit Margin
-39.94%
Dividend Yield
0.04%
613 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.91B | 0.61% | 1,264,884 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.15B | -0.21% | 906,900 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 59.34B | -1.06% | 967,524 | 3.21B |
| 4 | ARGX | argenx SE | 55.44B | 1.82% | 447,525 | 3.68B |
| 5 | INSM | Insmed Incorporated | 41.21B | 1.18% | 2,551,000 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 40.48B | -0.69% | 230,135 | 5.00B |
| 7 | BNTX | BioNTech SE | 24.79B | -0.76% | 1,285,658 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.60B | -0.33% | 2,568,800 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.45B | -1.20% | 2,034,966 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.71B | 0.07% | 1,426,481 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.11B | -1.31% | 8,290,022 | 20.33M |
| 12 | SMMT | Summit Therapeutics Inc. | 13.42B | -1.26% | 1,444,855 | - |
| 13 | RVMD | Revolution Medicines, Inc. | 13.10B | 5.23% | 3,957,761 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 12.79B | 2.04% | 1,539,272 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 12.49B | -0.99% | 1,053,823 | 758.59M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.02B | 2.77% | 263,415 | 740.64M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.59B | 2.45% | 3,508,843 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.21B | -1.65% | 2,571,943 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.67B | -0.06% | 2,394,961 | 20.87M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | 0.94% | 1,973,389 | 3.09B |
| 21 | MRNA | Moderna, Inc. | 9.68B | -0.76% | 8,954,873 | 2.23B |
| 22 | TECH | Bio-Techne Corporation | 9.25B | -2.26% | 1,968,528 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 8.57B | -0.45% | 810,366 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.27B | 9.41% | 2,422,574 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.24B | -1.63% | 1,706,283 | 1.24B |
| 26 | CYTK | Cytokinetics, Incorporated | 8.12B | 1.40% | 2,150,299 | 87.21M |
| 27 | CORT | Corcept Therapeutics Incorporated | 7.95B | -0.32% | 372,650 | 741.17M |
| 28 | MRUS | Merus N.V. | 7.28B | -0.07% | 1,124,266 | 56.61M |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.04B | 1.67% | 400,084 | 561.26M |
| 30 | NUVL | Nuvalent, Inc. | 7.02B | 1.92% | 333,871 | - |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.84B | 105.41% | 17,288,176 | 302.00K |
| 32 | CAI | Caris Life Sciences, Inc. | 6.73B | -1.85% | 1,603,000 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.63B | 3.67% | 768,342 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.37B | 6.89% | 2,205,756 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.05B | 0.47% | 922,481 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.98B | 2.46% | 173,741 | 373.16M |
| 37 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.70B | 0.29% | 1,621,072 | 572.98M |
| 38 | LEGN | Legend Biotech Corporation | 5.59B | -2.32% | 1,348,908 | 909.05M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.29B | 1.65% | 703,293 | 209.22M |
| 40 | ACLX | Arcellx, Inc. | 5.20B | 2.95% | 896,929 | 35.90M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.10B | -0.86% | 5,452,634 | - |
| 42 | CRSP | CRISPR Therapeutics AG | 5.01B | 2.78% | 4,265,658 | 38.34M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.67B | 2.06% | 1,146,189 | 43.74M |
| 44 | PRAX | Praxis Precision Medicines, Inc. | 4.66B | 4.68% | 868,141 | 7.46M |
| 45 | TGTX | TG Therapeutics, Inc. | 4.53B | 0.13% | 1,329,809 | 531.90M |
| 46 | AKRO | Akero Therapeutics, Inc. | 4.47B | 0.09% | 1,788,681 | - |
| 47 | VKTX | Viking Therapeutics, Inc. | 4.42B | 0.28% | 3,432,156 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.42B | 4.02% | 1,020,581 | - |
| 49 | NAMS | NewAmsterdam Pharma Company N.V. | 4.35B | 5.30% | 1,576,721 | 35.24M |
| 50 | CELC | Celcuity Inc. | 4.29B | 7.77% | 1,312,133 | - |
| 51 | IMVT | Immunovant, Inc. | 4.16B | 4.03% | 1,558,997 | - |
| 52 | BLTE | Belite Bio, Inc | 4.07B | 3.83% | 58,926 | - |
| 53 | ACAD | ACADIA Pharmaceuticals Inc. | 4.06B | 1.61% | 1,238,233 | 1.05B |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.05B | 2.99% | 1,445,443 | 1.54M |
| 55 | CNTA | Centessa Pharmaceuticals plc | 4.03B | 6.31% | 3,530,262 | 15.00M |
| 56 | SRRK | Scholar Rock Holding Corporation | 3.82B | 24.41% | 7,132,667 | - |
| 57 | ADMA | ADMA Biologics, Inc. | 3.70B | -0.89% | 2,825,505 | 488.56M |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.67B | 3.18% | 449,737 | 471.79M |
| 59 | IRON | Disc Medicine, Inc. | 3.40B | 3.34% | 553,820 | - |
| 60 | CGON | CG Oncology, Inc. | 3.31B | 8.61% | 1,408,575 | 2.17M |
| 61 | MLYS | Mineralys Therapeutics, Inc. | 3.23B | -7.77% | 6,509,292 | - |
| 62 | AAPG | Ascentage Pharma Group International | 3.20B | 1.31% | 8,241 | 54.52M |
| 63 | RARE | Ultragenyx Pharmaceutical Inc. | 3.19B | 0.55% | 1,265,295 | 630.60M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.15B | 1.80% | 1,060,480 | 7.50M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.13B | -1.89% | 127,516 | 664.23M |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 3.10B | 0.54% | 253,250 | 366.10M |
| 67 | TVTX | Travere Therapeutics, Inc. | 3.09B | 1.80% | 1,216,895 | 435.83M |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.06B | 9.36% | 3,953,890 | 317.93M |
| 69 | FOLD | Amicus Therapeutics, Inc. | 2.92B | 1.12% | 2,742,399 | 598.70M |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | 0.70% | 1,110,380 | 578.20M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | 1.01% | 1,059,746 | 214.83M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.75B | 0.98% | 2,728,916 | 70.79M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.68B | -0.21% | 1,896,103 | - |
| 74 | SLNO | Soleno Therapeutics, Inc. | 2.65B | 4.37% | 1,434,421 | 98.68M |
| 75 | APLS | Apellis Pharmaceuticals, Inc. | 2.57B | 2.62% | 2,469,437 | 1.02B |
| 76 | DNLI | Denali Therapeutics Inc. | 2.56B | 1.69% | 1,280,401 | - |
| 77 | AGIO | Agios Pharmaceuticals, Inc. | 2.55B | 2.61% | 842,073 | 44.79M |
| 78 | LQDA | Liquidia Corporation | 2.44B | 4.08% | 2,042,342 | 69.22M |
| 79 | EWTX | Edgewise Therapeutics, Inc. | 2.41B | 11.41% | 2,512,831 | - |
| 80 | OCUL | Ocular Therapeutix, Inc. | 2.41B | 0.98% | 1,338,441 | 55.78M |
| 81 | ZLAB | Zai Lab Limited | 2.41B | 0.09% | 504,333 | 441.63M |
| 82 | GPCR | Structure Therapeutics Inc. | 2.23B | 5.20% | 1,808,580 | - |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.17B | 1.41% | 924,838 | 240.00M |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.16B | -4.39% | 31,402,570 | 43.69M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.15B | -0.28% | 1,627,684 | 252.75M |
| 86 | BEAM | Beam Therapeutics Inc. | 2.14B | 0.28% | 2,202,500 | 55.70M |
| 87 | GLPG | Galapagos NV | 2.09B | -0.57% | 173,924 | 336.64M |
| 88 | IBRX | ImmunityBio, Inc. | 2.05B | 4.00% | 7,172,759 | 82.56M |
| 89 | TERN | Terns Pharmaceuticals, Inc. | 2.03B | 8.83% | 3,930,136 | - |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 0.85% | 1,420,361 | 265.81M |
| 91 | VCEL | Vericel Corporation | 2.02B | 0.05% | 423,411 | 258.72M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | 5.56% | 8,044,317 | 2.41B |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -0.76% | 723,250 | 825.94M |
| 94 | ZBIO | Zenas BioPharma, Inc. | 1.88B | -1.85% | 284,500 | 15.00M |
| 95 | MESO | Mesoblast Limited | 1.87B | -1.01% | 129,964 | 17.20M |
| 96 | QURE | uniQure N.V. | 1.86B | -1.52% | 1,829,546 | 15.75M |
| 97 | SYRE | Spyre Therapeutics, Inc. | 1.82B | 3.84% | 541,733 | - |
| 98 | IMCR | Immunocore Holdings plc | 1.82B | 1.75% | 178,276 | 379.59M |
| 99 | VERA | Vera Therapeutics, Inc. | 1.81B | -0.07% | 1,249,676 | - |
| 100 | JANX | Janux Therapeutics, Inc. | 1.76B | 6.63% | 1,318,893 | 10.00M |
| 101 | DNTH | Dianthus Therapeutics, Inc. | 1.75B | 15.07% | 1,574,892 | 3.08M |
| 102 | PGEN | Precigen, Inc. | 1.72B | 25.65% | 16,789,082 | 6.31M |
| 103 | PHVS | Pharvaris N.V. | 1.70B | -2.84% | 360,556 | - |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.70B | 7.72% | 961,843 | 2.60M |
| 105 | NUVB | Nuvation Bio Inc. | 1.67B | 3.62% | 11,448,356 | 26.75M |
| 106 | INVA | Innoviva, Inc. | 1.66B | 0.23% | 766,176 | 388.52M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.65B | 3.12% | 116,763 | - |
| 108 | IMNM | Immunome, Inc. | 1.57B | 3.82% | 2,006,269 | 9.68M |
| 109 | MAZE | Maze Therapeutics, Inc. | 1.57B | 2.14% | 909,138 | 2.50M |
| 110 | MNKD | MannKind Corporation | 1.55B | -0.20% | 3,459,990 | 313.79M |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.51B | 1.69% | 1,013,719 | 205.63M |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.46B | -0.79% | 1,474,122 | - |
| 113 | SNDX | Syndax Pharmaceuticals, Inc. | 1.44B | -0.24% | 2,325,550 | 111.30M |
| 114 | ARDX | Ardelyx, Inc. | 1.42B | 0.51% | 2,884,719 | 398.23M |
| 115 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.39B | 2.21% | 1,561,336 | -665.00K |
| 116 | ZYME | Zymeworks Inc. | 1.39B | 0.11% | 809,698 | 134.48M |
| 117 | UPB | Upstream Bio, Inc. | 1.33B | 5.10% | 801,193 | 2.80M |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.31B | 2.65% | 304,363 | - |
| 119 | ELVN | Enliven Therapeutics, Inc. | 1.31B | 8.88% | 562,701 | - |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.30B | 2.98% | 1,270,113 | 83.69M |
| 121 | IMTX | Immatics N.V. | 1.24B | 2.20% | 538,496 | 152.82M |
| 122 | ORIC | ORIC Pharmaceuticals, Inc. | 1.19B | 0.49% | 1,563,959 | - |
| 123 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | -1.10% | 2,959,619 | 266.14M |
| 124 | CVAC | CureVac N.V. | 1.19B | -0.38% | 579,239 | 599.54M |
| 125 | WVE | Wave Life Sciences Ltd. | 1.18B | 6.15% | 2,312,807 | 109.23M |
| 126 | RAPP | Rapport Therapeutics, Inc. | 1.16B | -1.36% | 278,907 | - |
| 127 | PHAR | Pharming Group N.V. | 1.16B | -4.60% | 17,183 | 362.27M |
| 128 | NKTR | Nektar Therapeutics | 1.15B | 5.06% | 674,935 | 62.60M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.15B | 6.04% | 599,053 | 1.40M |
| 130 | NVAX | Novavax, Inc. | 1.13B | -1.27% | 3,489,299 | 1.06B |
| 131 | TSHA | Taysha Gene Therapies, Inc. | 1.13B | 2.99% | 3,443,908 | 6.31M |
| 132 | MNMD | Mind Medicine (MindMed) Inc. | 1.12B | -2.41% | 2,050,679 | - |
| 133 | MBX | MBX Biosciences, Inc. | 1.11B | 2.99% | 617,713 | - |
| 134 | URGN | UroGen Pharma Ltd. | 1.11B | -0.67% | 1,030,308 | 96.52M |
| 135 | ABCL | AbCellera Biologics Inc. | 1.10B | 1.93% | 4,265,144 | 35.33M |
| 136 | BHVN | Biohaven Ltd. | 1.10B | 2.72% | 4,814,308 | - |
| 137 | TNGX | Tango Therapeutics, Inc. | 1.10B | 5.83% | 2,999,353 | 66.50M |
| 138 | MDXG | MiMedx Group, Inc. | 1.09B | -1.20% | 734,704 | 393.44M |
| 139 | RLAY | Relay Therapeutics, Inc. | 1.09B | -2.48% | 2,391,363 | 8.36M |
| 140 | XNCR | Xencor, Inc. | 1.07B | 6.72% | 788,523 | 150.13M |
| 141 | SANA | Sana Biotechnology, Inc. | 1.06B | 9.02% | 4,178,260 | - |
| 142 | SEPN | Septerna, Inc. | 1.04B | 20.92% | 1,521,521 | 22.05M |
| 143 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.04B | 5.98% | 130,374 | - |
| 144 | SVRA | Savara Inc. | 1.04B | 0.94% | 1,219,035 | - |
| 145 | KOD | Kodiak Sciences Inc. | 1.03B | 3.39% | 683,567 | - |
| 146 | OCS | Oculis Holding AG | 1.03B | 1.61% | 197,115 | 992.00K |
| 147 | NBTX | Nanobiotix S.A. | 1.02B | 2.61% | 36,710 | 11.93M |
| 148 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | -1.95% | 970,861 | 147.19M |
| 149 | NTLA | Intellia Therapeutics, Inc. | 1.01B | 0.35% | 6,863,892 | 57.53M |
| 150 | PVLA | Palvella Therapeutics, Inc. | 990.95M | 3.88% | 186,096 | - |
| 151 | IOVA | Iovance Biotherapeutics, Inc. | 980.51M | 2.49% | 16,041,358 | 250.43M |
| 152 | KURA | Kura Oncology, Inc. | 975.03M | 4.92% | 4,492,925 | 104.03M |
| 153 | FTRE | Fortrea Holdings Inc. | 961.88M | 1.76% | 796,818 | 2.76B |
| 154 | EYPT | EyePoint Pharmaceuticals, Inc. | 958.68M | 0.65% | 1,120,034 | 42.34M |
| 155 | ANAB | AnaptysBio, Inc. | 936.42M | 1.68% | 746,289 | 169.47M |
| 156 | GLUE | Monte Rosa Therapeutics, Inc. | 935.09M | 0.35% | 1,674,874 | 181.54M |
| 157 | MRVI | Maravai LifeSciences Holdings, Inc. | 930.77M | 12.00% | 2,026,958 | 192.44M |
| 158 | RZLT | Rezolute, Inc. | 915.22M | -0.70% | 1,310,259 | - |
| 159 | MLTX | MoonLake Immunotherapeutics | 911.44M | 1.67% | 1,413,491 | - |
| 160 | DAWN | Day One Biopharmaceuticals, Inc. | 903.54M | -0.56% | 3,549,359 | 133.67M |
| 161 | CRMD | CorMedix Inc. | 885.59M | 0.27% | 3,075,896 | 214.30M |
| 162 | TBPH | Theravance Biopharma, Inc. | 881.19M | -3.23% | 474,455 | 80.33M |
| 163 | ABUS | Arbutus Biopharma Corporation | 869.30M | -0.88% | 878,268 | 14.61M |
| 164 | GHRS | GH Research PLC | 868.41M | 2.04% | 233,705 | - |
| 165 | YDES | YD Bio Limited | 861.42M | 21.05% | 178,298 | 510.36K |
| 166 | CMPX | Compass Therapeutics, Inc. | 859.07M | 1.26% | 1,523,431 | 850.00K |
| 167 | ATAI | Atai Beckley N.V. | 857.35M | -3.15% | 6,026,414 | 3.02M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 854.11M | 5.13% | 406,475 | - |
| 169 | TYRA | Tyra Biosciences, Inc. | 839.54M | 0.90% | 344,827 | - |
| 170 | SPRY | ARS Pharmaceuticals, Inc. | 811.55M | -2.38% | 1,965,466 | 142.77M |
| 171 | BCAX | Bicara Therapeutics Inc. | 809.68M | 3.51% | 459,855 | - |
| 172 | LENZ | LENZ Therapeutics, Inc. | 801.02M | -3.36% | 1,055,269 | 17.50M |
| 173 | RAPT | RAPT Therapeutics, Inc. | 799.46M | 3.81% | 283,140 | - |
| 174 | VIR | Vir Biotechnology, Inc. | 783.27M | 2.93% | 1,260,579 | 16.86M |
| 175 | VALN | Valneva SE | 771.27M | -1.95% | 8,367 | 230.57M |
| 176 | RIGL | Rigel Pharmaceuticals, Inc. | 761.27M | 5.17% | 714,498 | 282.08M |
| 177 | ERAS | Erasca, Inc. | 731.98M | 1.57% | 1,477,248 | - |
| 178 | GYRE | Gyre Therapeutics, Inc. | 726.21M | -1.11% | 64,149 | 107.27M |
| 179 | PROK | ProKidney Corp. | 725.01M | 5.70% | 1,335,171 | 744.00K |
| 180 | ATXS | Astria Therapeutics, Inc. | 717.56M | 1.05% | 837,167 | 706.00K |
| 181 | GERN | Geron Corporation | 714.96M | -2.61% | 8,042,850 | 183.40M |
| 182 | REPL | Replimune Group, Inc. | 705.21M | 0.11% | 1,743,077 | - |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 688.44M | 4.05% | 1,337,627 | 1.43M |
| 184 | ARVN | Arvinas, Inc. | 678.85M | 4.45% | 2,455,662 | 312.30M |
| 185 | VTYX | Ventyx Biosciences, Inc. | 660.07M | -3.14% | 2,715,948 | - |
| 186 | LXEO | Lexeo Therapeutics, Inc. | 659.81M | 0.56% | 479,671 | - |
| 187 | MGTX | MeiraGTx Holdings plc | 659.22M | -0.97% | 486,769 | 27.42M |
| 188 | CTMX | CytomX Therapeutics, Inc. | 657.41M | 0.52% | 3,669,963 | 113.63M |
| 189 | CRVS | Corvus Pharmaceuticals, Inc. | 654.96M | 9.62% | 1,157,084 | - |
| 190 | GOSS | Gossamer Bio, Inc. | 627.25M | 7.97% | 2,785,234 | 44.05M |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 616.49M | 4.96% | 774,936 | 120.00K |
| 192 | MPLT | MapLight Therapeutics, Inc. | 614.91M | -1.33% | 80,452 | - |
| 193 | PRME | Prime Medicine, Inc. | 596.62M | 1.20% | 4,071,058 | 5.98M |
| 194 | RGNX | REGENXBIO Inc. | 582.67M | -1.12% | 512,048 | 161.32M |
| 195 | ASMB | Assembly Biosciences, Inc. | 580.65M | 3.35% | 382,798 | 37.19M |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 576.74M | 5.92% | 712,231 | - |
| 197 | ALMS | Alumis Inc. | 576.25M | 4.55% | 1,721,452 | 22.12M |
| 198 | OMER | Omeros Corporation | 557.99M | 25.32% | 4,819,835 | - |
| 199 | ENGN | enGene Holdings Inc. | 550.85M | 1.19% | 1,201,843 | - |
| 200 | EVMN | Evommune, Inc. | 550.42M | 0.44% | 169,133 | 3.00M |
| 201 | NAGE | Niagen Bioscience, Inc. | 550.21M | -1.72% | 623,262 | 124.71M |
| 202 | IVA | Inventiva S.A. | 548.01M | 4.45% | 226,716 | 19.93M |
| 203 | IVVD | Invivyd, Inc. | 547.84M | 32.77% | 136,449,892 | 50.04M |
| 204 | LXRX | Lexicon Pharmaceuticals, Inc. | 541.46M | 3.47% | 2,233,767 | 70.86M |
| 205 | PRTA | Prothena Corporation plc | 534.53M | -2.46% | 504,442 | 11.79M |
| 206 | KROS | Keros Therapeutics, Inc. | 525.84M | -0.26% | 971,228 | 246.72M |
| 207 | MNPR | Monopar Therapeutics Inc. | 521.24M | -10.31% | 273,198 | - |
| 208 | CGEM | Cullinan Therapeutics, Inc. | 505.10M | 3.39% | 997,806 | - |
| 209 | VSTM | Verastem, Inc. | 504.49M | -6.84% | 2,806,382 | 13.38M |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 499.92M | -3.79% | 1,767,379 | 84.39M |
| 211 | ADCT | ADC Therapeutics SA | 490.55M | -2.22% | 591,989 | 75.21M |
| 212 | NBP | NovaBridge Biosciences | 478.35M | -0.48% | 321,759 | - |
| 213 | FULC | Fulcrum Therapeutics, Inc. | 468.12M | -1.59% | 473,722 | 80.00M |
| 214 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 456.40M | 0.37% | 1,126,909 | 180.61M |
| 216 | LCTX | Lineage Cell Therapeutics, Inc. | 455.58M | 4.44% | 1,366,458 | 10.82M |
| 217 | DBVT | DBV Technologies S.A. | 455.36M | 1.84% | 18,179 | 5.50M |
| 218 | DRUG | Bright Minds Biosciences Inc. | 451.41M | -0.81% | 207,257 | - |
| 219 | BCYC | Bicycle Therapeutics plc | 449.50M | -1.52% | 286,564 | 28.34M |
| 220 | BNTC | Benitec Biopharma Inc. | 445.63M | 0.08% | 217,543 | - |
| 221 | NMRA | Neumora Therapeutics, Inc. | 442.79M | -1.49% | 811,897 | - |
| 222 | ALT | Altimmune, Inc. | 435.11M | 2.71% | 2,628,142 | 20.00K |
| 223 | ABSI | Absci Corporation | 424.05M | 6.82% | 7,296,608 | 2.82M |
| 224 | DSGN | Design Therapeutics, Inc. | 419.82M | 4.39% | 793,668 | - |
| 225 | XOMA | XOMA Royalty Corporation | 404.18M | 1.24% | 37,807 | 47.11M |
| 226 | IMRX | Immuneering Corporation | 401.57M | -1.55% | 1,305,089 | - |
| 227 | PRTC | PureTech Health plc | 393.12M | -1.08% | 934 | 6.39M |
| 228 | ANNX | Annexon, Inc. | 392.22M | 1.12% | 3,505,303 | - |
| 229 | VTVT | vTv Therapeutics Inc. | 382.19M | -1.50% | 15,308 | 17.00K |
| 230 | LBRX | LB Pharmaceuticals Inc | 377.21M | 0.07% | 220,361 | - |
| 231 | OCGN | Ocugen, Inc. | 371.66M | -4.03% | 3,110,598 | 5.37M |
| 232 | AUTL | Autolus Therapeutics plc | 364.61M | 7.03% | 3,033,735 | 51.13M |
| 233 | GALT | Galectin Therapeutics Inc. | 355.28M | -0.36% | 238,869 | - |
| 234 | NGNE | Neurogene Inc. | 352.70M | -14.04% | 338,948 | 925.00K |
| 235 | AURA | Aura Biosciences, Inc. | 351.17M | - | 155,002 | - |
| 236 | JBIO | Jade Biosciences, Inc. | 349.11M | 10.54% | 580,830 | - |
| 237 | TECX | Tectonic Therapeutic, Inc. | 347.00M | 5.46% | 423,016 | - |
| 238 | ENTA | Enanta Pharmaceuticals, Inc. | 336.21M | 2.82% | 273,656 | 64.81M |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 335.95M | 4.18% | 269,622 | - |
| 240 | SLDB | Solid Biosciences Inc. | 330.34M | -1.40% | 1,580,699 | - |
| 241 | RCKT | Rocket Pharmaceuticals, Inc. | 330.08M | -3.79% | 4,130,543 | - |
| 242 | ANRO | Alto Neuroscience, Inc. | 327.90M | 6.70% | 436,949 | - |
| 243 | PEPG | PepGen Inc. | 325.81M | -3.07% | 338,624 | - |
| 244 | ACIU | AC Immune SA | 325.52M | 1.86% | 155,080 | 5.48M |
| 245 | LYEL | Lyell Immunopharma, Inc. | 325.25M | -3.45% | 18,285 | 41.00K |
| 246 | SLN | Silence Therapeutics plc | 322.61M | -1.30% | 279,316 | 25.83M |
| 247 | XFOR | X4 Pharmaceuticals, Inc. | 320.02M | -1.88% | 282,069 | 33.98M |
| 248 | PALI | Palisade Bio, Inc. | 318.87M | 14.44% | 5,517,278 | - |
| 249 | DRTS | Alpha Tau Medical Ltd. | 315.85M | -3.93% | 56,405 | - |
| 250 | TRDA | Entrada Therapeutics, Inc. | 313.79M | -0.34% | 644,715 | 61.52M |
| 251 | AVXL | Anavex Life Sciences Corp. | 313.08M | -35.94% | 22,983,365 | - |
| 252 | CTNM | Contineum Therapeutics, Inc. | 311.09M | -2.39% | 61,501 | - |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 308.82M | 9.41% | 642,151 | - |
| 254 | ALDX | Aldeyra Therapeutics, Inc. | 303.82M | 0.60% | 580,222 | - |
| 255 | KYTX | Kyverna Therapeutics, Inc. | 297.53M | 6.17% | 388,191 | - |
| 256 | RLMD | Relmada Therapeutics, Inc. | 289.67M | 1.80% | 2,301,122 | - |
| 257 | LRMR | Larimar Therapeutics, Inc. | 289.30M | 2.74% | 721,799 | - |
| 258 | CLLS | Cellectis S.A. | 286.09M | 9.24% | 218,655 | 82.55M |
| 259 | TENX | Tenax Therapeutics, Inc. | 283.93M | 6.13% | 155,204 | - |
| 260 | MREO | Mereo BioPharma Group plc | 283.25M | - | 847,742 | 500.00K |
| 261 | ALLO | Allogene Therapeutics, Inc. | 276.42M | 2.50% | 2,647,052 | 22.00K |
| 262 | AVTX | Avalo Therapeutics, Inc. | 274.00M | 2.58% | 521,875 | 192.00K |
| 263 | ACRS | Aclaris Therapeutics, Inc. | 273.03M | 8.62% | 2,433,911 | 15.74M |
| 264 | PYXS | Pyxis Oncology, Inc. | 271.47M | -2.68% | 665,428 | 2.82M |
| 265 | ZURA | Zura Bio Limited | 265.27M | -2.39% | 398,280 | - |
| 266 | FHTX | Foghorn Therapeutics Inc. | 265.23M | 7.57% | 127,004 | 24.52M |
| 267 | ARMP | Armata Pharmaceuticals, Inc. | 265.20M | 14.73% | 149,741 | 5.05M |
| 268 | IMMP | Immutep Limited | 265.12M | 0.54% | 162,700 | 3.31M |
| 269 | FENC | Fennec Pharmaceuticals Inc. | 257.68M | 2.21% | 911,416 | 38.79M |
| 270 | VNDA | Vanda Pharmaceuticals Inc. | 257.07M | 0.23% | 318,064 | 212.07M |
| 271 | CAPR | Capricor Therapeutics, Inc. | 256.02M | -2.95% | 1,092,905 | 11.13M |
| 272 | CADL | Candel Therapeutics, Inc. | 254.73M | 0.65% | 554,145 | - |
| 273 | CBIO | Crescent Biopharma, Inc. | 254.54M | 0.35% | 32,829 | - |
| 274 | EDIT | Editas Medicine, Inc. | 253.81M | 2.36% | 1,769,543 | 46.38M |
| 275 | SGMT | Sagimet Biosciences Inc. | 252.04M | 0.13% | 354,525 | - |
| 276 | FBRX | Forte Biosciences, Inc. | 251.09M | 3.90% | 44,996 | - |
| 277 | PBYI | Puma Biotechnology, Inc. | 246.41M | -1.21% | 460,406 | 212.00M |
| 278 | ABEO | Abeona Therapeutics Inc. | 241.15M | -1.77% | 2,635,977 | 400.00K |
| 279 | CCCC | C4 Therapeutics, Inc. | 239.38M | 0.82% | 793,864 | 30.11M |
| 280 | ETHZ | ETHZilla Corporation | 238.02M | -8.16% | 796,317 | 4.11M |
| 281 | MDWD | MediWound Ltd. | 233.99M | -0.71% | 56,147 | 19.86M |
| 282 | ACHV | Achieve Life Sciences, Inc. | 233.16M | -4.37% | 438,921 | - |
| 283 | AVIR | Atea Pharmaceuticals, Inc. | 232.04M | -2.94% | 235,011 | - |
| 284 | HUMA | Humacyte, Inc. | 230.34M | 3.36% | 5,902,094 | 1.57M |
| 285 | PRQR | ProQR Therapeutics N.V. | 228.60M | 0.46% | 302,035 | 18.86M |
| 286 | BDTX | Black Diamond Therapeutics, Inc. | 228.47M | -10.69% | 1,703,677 | 70.00M |
| 287 | RANI | Rani Therapeutics Holdings, Inc. | 228.44M | -2.59% | 2,690,852 | 1.20M |
| 288 | NAUT | Nautilus Biotechnology, Inc. | 227.35M | -4.76% | 294,250 | - |
| 289 | OABI | OmniAb, Inc. | 224.57M | 2.63% | 364,231 | 21.09M |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 222.47M | -5.86% | 200,240 | 2.82M |
| 291 | CABA | Cabaletta Bio, Inc. | 222.37M | -1.28% | 2,549,495 | - |
| 292 | VYGR | Voyager Therapeutics, Inc. | 218.51M | -1.13% | 445,900 | 31.32M |
| 293 | GNFT | Genfit S.A. | 217.51M | 2.41% | 30,788 | 52.99M |
| 294 | TNYA | Tenaya Therapeutics, Inc. | 216.76M | -2.92% | 1,924,198 | - |
| 295 | AARD | Aardvark Therapeutics, Inc. | 215.99M | -8.66% | 93,905 | - |
| 296 | TARA | Protara Therapeutics, Inc. | 212.62M | 4.55% | 425,172 | - |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 206.56M | -6.44% | 1,126,496 | 97.60M |
| 298 | TLSA | Tiziana Life Sciences Ltd | 204.38M | 4.24% | 157,147 | - |
| 299 | VOR | Vor Biopharma Inc. | 204.31M | 2.67% | 523,659 | - |
| 300 | SLS | SELLAS Life Sciences Group, Inc. | 203.69M | -2.05% | 3,261,569 | - |
| 301 | HRTX | Heron Therapeutics, Inc. | 201.70M | -0.90% | 1,102,123 | 155.10M |
| 302 | GNLX | Genelux Corporation | 200.13M | -3.45% | 204,010 | 8.00K |
| 303 | MIST | Milestone Pharmaceuticals Inc. | 196.16M | 5.26% | 3,158,742 | - |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 193.99M | 3.32% | 96,751 | 1.09M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 192.21M | -3.98% | 54,498 | 3.80M |
| 306 | TNXP | Tonix Pharmaceuticals Holding Corp. | 187.25M | -1.55% | 444,724 | 10.30M |
| 307 | CRBU | Caribou Biosciences, Inc. | 185.32M | 0.25% | 1,379,425 | 9.30M |
| 308 | NTHI | NeOnc Technologies Holdings, Inc. | 173.96M | 1.11% | 69,119 | 59.99K |
| 309 | IPHA | Innate Pharma S.A. | 169.81M | - | 36,694 | 14.84M |
| 310 | GUTS | Fractyl Health, Inc. | 166.56M | 12.50% | 3,330,900 | 3.00K |
| 311 | CYBN | Cybin Inc. | 163.82M | -0.17% | 461,835 | - |
| 312 | MOLN | Molecular Partners AG | 160.29M | -1.40% | 2,213 | 856.30K |
| 313 | ELTX | Elicio Therapeutics, Inc. | 155.70M | -3.18% | 130,772 | - |
| 314 | NVCT | Nuvectis Pharma, Inc. | 154.20M | 1.69% | 50,191 | - |
| 315 | CGEN | Compugen Ltd. | 153.40M | -0.61% | 195,739 | 6.90M |
| 316 | MCRB | Seres Therapeutics, Inc. | 150.72M | -0.66% | 102,718 | 351.00K |
| 317 | SGMO | Sangamo Therapeutics, Inc. | 149.64M | -1.00% | 3,344,255 | 32.88M |
| 318 | PLX | Protalix BioTherapeutics, Inc. | 149.58M | -3.63% | 661,928 | 61.84M |
| 319 | CDXS | Codexis, Inc. | 148.58M | 0.92% | 1,415,081 | 52.93M |
| 320 | CHRS | Coherus Oncology, Inc. | 143.84M | -5.56% | 1,478,604 | 277.73M |
| 321 | CRDF | Cardiff Oncology, Inc. | 143.48M | -0.93% | 814,007 | 501.00K |
| 322 | DTIL | Precision BioSciences, Inc. | 141.54M | 0.51% | 189,351 | 698.00K |
| 323 | IMMX | Immix Biopharma, Inc. | 141.36M | 16.62% | 1,183,399 | - |
| 324 | INO | Inovio Pharmaceuticals, Inc. | 140.84M | 5.13% | 1,487,066 | 182.34K |
| 325 | MRSN | Mersana Therapeutics, Inc. | 139.34M | 1.79% | 420,209 | 33.18M |
| 326 | AGEN | Agenus Inc. | 138.29M | - | 364,358 | 106.83M |
| 327 | ACTU | Actuate Therapeutics, Inc. | 137.37M | 0.51% | 14,500 | - |
| 328 | CGTX | Cognition Therapeutics, Inc. | 136.83M | 0.65% | 907,501 | - |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 135.67M | - | 295,931 | - |
| 330 | SPRO | Spero Therapeutics, Inc. | 135.62M | -1.23% | 251,250 | 40.55M |
| 331 | ALEC | Alector, Inc. | 135.35M | 3.33% | 1,647,581 | 69.05M |
| 332 | ANIX | Anixa Biosciences, Inc. | 135.29M | -6.38% | 268,599 | - |
| 333 | SAVA | Cassava Sciences, Inc. | 133.33M | -6.12% | 876,548 | - |
| 334 | NKTX | Nkarta, Inc. | 132.83M | -0.53% | 689,171 | - |
| 335 | CLYM | Climb Bio, Inc. | 130.23M | 2.14% | 388,998 | - |
| 336 | NBY | NovaBay Pharmaceuticals, Inc. | 129.79M | -6.36% | 74,681 | 10.30M |
| 337 | EXOZ | eXoZymes, Inc. | 127.99M | -6.95% | 2,788 | -700.00 |
| 338 | ACOG | Alpha Cognition Inc. | 124.16M | -1.99% | 144,293 | 7.43M |
| 339 | ENTX | Entera Bio Ltd. | 123.75M | -1.09% | 49,405 | 166.00K |
| 340 | STTK | Shattuck Labs, Inc. | 118.97M | 2.17% | 110,183 | 1.00M |
| 341 | IRD | Opus Genetics, Inc. | 118.53M | 1.62% | 382,885 | 14.63M |
| 342 | CNTB | Connect Biopharma Holdings Limited | 118.13M | 26.19% | 1,043,551 | 762.00K |
| 343 | VTGN | Vistagen Therapeutics, Inc. | 116.59M | - | 308,291 | 721.00K |
| 344 | PRLD | Prelude Therapeutics Incorporated | 115.72M | 0.66% | 572,382 | 10.50M |
| 345 | GLSI | Greenwich LifeSciences, Inc. | 115.27M | 1.34% | 44,355 | - |
| 346 | IKT | Inhibikase Therapeutics, Inc. | 115.02M | -4.38% | 76,766 | 1.00 |
| 347 | SPRB | Spruce Biosciences, Inc. | 113.83M | -5.53% | 179,063 | 697.00K |
| 348 | TTRX | Turn Therapeutics Inc. | 112.09M | -2.20% | 64,046 | - |
| 349 | SEER | Seer, Inc. | 111.58M | -1.96% | 380,372 | 16.38M |
| 350 | SRZN | Surrozen, Inc. | 111.26M | 7.10% | 58,430 | 3.60M |
| 351 | FATE | Fate Therapeutics, Inc. | 111.20M | -2.85% | 2,845,208 | 7.14M |
| 352 | ACET | Adicet Bio, Inc. | 107.09M | -0.12% | 868,367 | - |
| 353 | CNTX | Context Therapeutics Inc. | 106.58M | 0.87% | 420,089 | - |
| 354 | ELDN | Eledon Pharmaceuticals, Inc. | 105.68M | - | 2,935,331 | - |
| 355 | ONCY | Oncolytics Biotech Inc. | 105.30M | -3.70% | 850,344 | - |
| 356 | HURA | TuHURA Biosciences, Inc. | 105.08M | 1.23% | 162,117 | - |
| 357 | ABOS | Acumen Pharmaceuticals, Inc. | 104.79M | -4.42% | 88,617 | - |
| 358 | ATOS | Atossa Therapeutics, Inc. | 103.34M | -0.34% | 482,955 | - |
| 359 | PLRX | Pliant Therapeutics, Inc. | 103.23M | -2.33% | 498,342 | - |
| 360 | PTHS | Pelthos Therapeutics Inc. | 103.11M | -3.09% | 42,068 | 7.41M |
| 361 | KLRS | Kalaris Therapeutics, Inc. | 102.12M | 2.44% | 48,448 | - |
| 362 | GANX | Gain Therapeutics, Inc. | 101.73M | -5.35% | 1,192,147 | - |
| 363 | WHWK | Whitehawk Therapeutics, Inc. | 100.85M | 2.39% | 180,171 | 14.38M |
| 364 | THAR | Tharimmune, Inc. | 100.57M | -3.32% | 646,067 | - |
| 365 | UNCY | Unicycive Therapeutics, Inc. | 100.14M | 6.38% | 905,182 | - |
| 366 | COYA | Coya Therapeutics, Inc. | 98.18M | -1.51% | 116,772 | 3.99M |
| 367 | TIL | Instil Bio, Inc. | 97.35M | 3.67% | 48,926 | - |
| 368 | VXRT | Vaxart, Inc. | 97.02M | 10.96% | 855,871 | 148.20M |
| 369 | KPTI | Karyopharm Therapeutics Inc. | 96.85M | 3.55% | 95,335 | 142.53M |
| 370 | ATRA | Atara Biotherapeutics, Inc. | 96.64M | 2.76% | 43,929 | 151.93M |
| 371 | ZNTL | Zentalis Pharmaceuticals, Inc. | 95.94M | 1.14% | 434,732 | 26.87M |
| 372 | MGNX | MacroGenics, Inc. | 94.81M | -6.25% | 1,801,885 | 127.63M |
| 373 | SLGL | Sol-Gel Technologies Ltd. | 94.72M | -4.65% | 15,793 | 23.93M |
| 374 | ADVM | Adverum Biotechnologies, Inc. | 94.71M | 0.70% | 213,466 | 1.00M |
| 375 | CSBR | Champions Oncology, Inc. | 93.76M | -1.45% | 23,488 | 56.88M |
| 376 | ANEB | Anebulo Pharmaceuticals, Inc. | 93.67M | -3.80% | 20,435 | - |
| 377 | ORMP | Oramed Pharmaceuticals Inc. | 92.85M | -2.92% | 74,358 | 2.00M |
| 378 | OVID | Ovid Therapeutics Inc. | 92.80M | 8.75% | 1,096,548 | 6.61M |
| 379 | IFRX | InflaRx N.V. | 91.46M | 6.30% | 1,490,800 | 73.73K |
| 380 | IMA | ImageneBio, Inc. | 91.30M | -2.76% | 34,606 | 800.00K |
| 381 | BMEA | Biomea Fusion, Inc. | 90.50M | -0.78% | 698,611 | - |
| 382 | QNCX | Quince Therapeutics, Inc. | 90.24M | - | 290,547 | - |
| 383 | ADAG | Adagene Inc. | 86.25M | 2.78% | 31,113 | 103.20K |
| 384 | OKYO | OKYO Pharma Limited | 84.40M | -6.11% | 229,040 | - |
| 385 | BYSI | BeyondSpring Inc. | 84.29M | 1.46% | 10,955 | 1.88M |
| 386 | ESLA | Estrella Immunopharma, Inc. | 84.14M | 3.18% | 129,258 | - |
| 387 | VANI | Vivani Medical, Inc. | 84.13M | 4.80% | 140,298 | - |
| 388 | TVGN | Tevogen Bio Holdings Inc. | 82.87M | -6.12% | 429,321 | - |
| 389 | XBIT | XBiotech Inc. | 80.49M | -0.38% | 59,265 | - |
| 390 | ARTV | Artiva Biotherapeutics, Inc. | 79.38M | -4.13% | 196,714 | 251.00K |
| 391 | FBIO | Fortress Biotech, Inc. | 77.96M | 5.22% | 434,966 | 59.30M |
| 392 | HYFT | MindWalk Holdings Corp. | 77.54M | 1.82% | 260,954 | 18.21M |
| 393 | STRO | Sutro Biopharma, Inc. | 77.03M | -2.60% | 761,470 | 105.65M |
| 394 | IMUX | Immunic, Inc. | 76.80M | 9.26% | 1,263,645 | - |
| 395 | MNOV | MediciNova, Inc. | 76.02M | 0.65% | 85,431 | 257.92K |
| 396 | ALXO | ALX Oncology Holdings Inc. | 73.90M | 13.11% | 826,007 | - |
| 397 | ATYR | aTyr Pharma, Inc. | 73.80M | 5.58% | 3,498,861 | 190.00K |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 73.13M | 2.06% | 127,800 | - |
| 399 | LITS | Lite Strategy, Inc. | 72.02M | 6.32% | 503,285 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 71.23M | 4.07% | 15,471 | 3.57M |
| 401 | CRVO | CervoMed Inc. | 71.06M | 5.93% | 65,500 | 6.16M |
| 402 | RPTX | Repare Therapeutics Inc. | 70.88M | -2.37% | 3,077,558 | 250.00K |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 70.46M | 8.21% | 1,187,067 | - |
| 404 | PSTV | Plus Therapeutics, Inc. | 70.29M | -2.22% | 2,459,168 | 5.26M |
| 405 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.16M | 4.52% | 10,282 | 263.56K |
| 406 | OTLK | Outlook Therapeutics, Inc. | 69.74M | 6.80% | 7,856,334 | 1.51M |
| 407 | ABVC | ABVC BioPharma, Inc. | 68.83M | 4.29% | 66,607 | 797.92K |
| 408 | CBUS | Cibus, Inc. | 66.17M | -2.40% | 135,795 | 3.79M |
| 409 | NTRB | Nutriband Inc. | 66.09M | -2.48% | 46,338 | 2.58M |
| 410 | MGX | Metagenomi, Inc. | 65.31M | 2.35% | 371,231 | 30.91M |
| 411 | TCRX | TScan Therapeutics, Inc. | 62.42M | -2.65% | 621,378 | 8.42M |
| 412 | EQ | Equillium, Inc. | 61.88M | 23.81% | 1,352,251 | 4.39M |
| 413 | OSTX | OS Therapies Incorporated | 60.36M | -1.10% | 638,133 | - |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 59.19M | -3.86% | 437,641 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 57.67M | -3.56% | 19,480 | - |
| 416 | ANL | Adlai Nortye Ltd. | 57.56M | 3.31% | 32,736 | 1.94M |
| 417 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 57.29M | -7.19% | 3,829,139 | - |
| 418 | KRRO | Korro Bio, Inc. | 57.16M | -6.62% | 2,066,836 | 7.37M |
| 419 | PYPD | PolyPid Ltd. | 56.20M | 0.28% | 8,473 | - |
| 420 | ANVS | Annovis Bio, Inc. | 54.53M | 2.18% | 617,541 | - |
| 421 | IOBT | IO Biotech, Inc. | 54.52M | 1.71% | 414,512 | - |
| 422 | CVM | CEL-SCI Corporation | 52.92M | -0.15% | 55,407 | - |
| 423 | APLM | Apollomics, Inc. | 52.67M | 17.08% | 55,871 | 198.00K |
| 424 | IBO | Impact BioMedical Inc. | 50.22M | -5.88% | 213,499 | 25.00K |
| 425 | ICCC | ImmuCell Corporation | 48.85M | -9.42% | 50,296 | 27.77M |
| 426 | CUE | Cue Biopharma, Inc. | 48.41M | 1.68% | 155,249 | 7.10M |
| 427 | JUNS | Jupiter Neurosciences, Inc. | 48.13M | 2.29% | 49,400 | - |
| 428 | JSPR | Jasper Therapeutics, Inc. | 47.01M | 4.35% | 341,422 | - |
| 429 | GRCE | Grace Therapeutics, Inc. | 46.43M | -1.29% | 42,370 | - |
| 430 | BCAB | BioAtla, Inc. | 46.39M | 19.75% | 5,658,786 | 11.00M |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 45.67M | 3.85% | 381,514 | - |
| 432 | KZR | Kezar Life Sciences, Inc. | 45.26M | 0.49% | 70,076 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 44.57M | -1.02% | 725,786 | 1.14M |
| 434 | PDSB | PDS Biotechnology Corporation | 44.35M | -0.53% | 475,008 | - |
| 435 | LVTX | LAVA Therapeutics N.V. | 43.40M | -2.43% | 46,538 | 4.99M |
| 436 | SER | Serina Therapeutics, Inc. | 43.10M | 4.34% | 16,168 | 116.00K |
| 437 | OKUR | OnKure Therapeutics, Inc. | 42.41M | -0.32% | 289,298 | - |
| 438 | SNTI | Senti Biosciences, Inc. | 42.12M | -10.06% | 129,021 | - |
| 439 | CALC | CalciMedica, Inc. | 41.92M | -7.12% | 7,857 | - |
| 440 | GNTA | Genenta Science S.p.A. | 41.55M | -0.46% | 57,921 | - |
| 441 | CELU | Celularity Inc. | 41.37M | -4.40% | 137,656 | 44.59M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 40.98M | 9.72% | 72,032 | 2.65M |
| 443 | IPSC | Century Therapeutics, Inc. | 40.80M | 1.68% | 990,181 | 113.34M |
| 444 | VERU | Veru Inc. | 40.77M | 1.20% | 74,483 | 16.89M |
| 445 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 40.42M | 9.63% | 1,590,188 | 1.00M |
| 446 | SKYE | Skye Bioscience, Inc. | 40.28M | -5.11% | 227,289 | - |
| 447 | TPST | Tempest Therapeutics, Inc. | 40.27M | 2.37% | 22,504 | - |
| 448 | RADX | Radiopharm Theranostics Limited | 40.07M | -3.08% | 11,682 | 8.20M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 39.62M | 1.60% | 63,002 | 81.00K |
| 450 | MAIA | MAIA Biotechnology, Inc. | 38.51M | 2.97% | 179,186 | - |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 37.81M | -1.95% | 220,814 | - |
| 452 | INMB | INmune Bio, Inc. | 37.75M | -0.70% | 331,368 | 50.00K |
| 453 | VRCA | Verrica Pharmaceuticals Inc. | 37.12M | 1.55% | 51,099 | 14.70M |
| 454 | XLO | Xilio Therapeutics, Inc. | 36.65M | 0.81% | 450,880 | 31.80M |
| 455 | GBIO | Generation Bio Co. | 36.52M | -3.56% | 19,779 | 15.27M |
| 456 | LTRN | Lantern Pharma Inc. | 36.50M | -2.31% | 34,221 | - |
| 457 | MURA | Mural Oncology plc | 36.21M | - | 55,704 | - |
| 458 | GLTO | Galecto, Inc. | 35.61M | -3.63% | 707,835 | - |
| 459 | BTAI | BioXcel Therapeutics, Inc. | 35.48M | 1.24% | 584,632 | 752.00K |
| 460 | FGEN | FibroGen, Inc. | 35.14M | -4.19% | 44,167 | 8.30M |
| 461 | HYPD | Hyperion DeFi, Inc. | 34.87M | 0.80% | 299,076 | 345.32K |
| 462 | EVAX | Evaxion A/S | 34.49M | -4.38% | 75,705 | 7.65M |
| 463 | SABS | SAB Biotherapeutics, Inc. | 33.73M | 4.52% | 268,124 | 114.70K |
| 464 | DYAI | Dyadic International, Inc. | 33.02M | 0.81% | 105,072 | 3.34M |
| 465 | IGC | IGC Pharma, Inc. | 32.92M | 0.56% | 356,898 | 1.33M |
| 466 | KLTO | Klotho Neurosciences, Inc. | 32.75M | -1.98% | 311,895 | - |
| 467 | BRNS | Barinthus Biotherapeutics plc | 32.46M | 1.66% | 335,552 | 14.97M |
| 468 | PLUR | Pluri Inc. | 31.48M | -7.66% | 113,743 | 1.33M |
| 469 | APLT | Applied Therapeutics, Inc. | 31.44M | -19.15% | 42,909,166 | 1.00M |
| 470 | ANTX | AN2 Therapeutics, Inc. | 31.15M | 0.88% | 70,594 | - |
| 471 | RNTX | Rein Therapeutics Inc. | 29.13M | -7.41% | 342,085 | - |
| 472 | LIMN | Liminatus Pharma, Inc. | 28.96M | - | 379,365 | - |
| 473 | NERV | Minerva Neurosciences, Inc. | 28.74M | 6.75% | 89,942 | - |
| 474 | QNTM | Quantum BioPharma Ltd. | 28.59M | -4.29% | 74,524 | - |
| 475 | PASG | Passage Bio, Inc. | 28.13M | 3.75% | 30,169 | - |
| 476 | BOLD | Boundless Bio, Inc. | 27.98M | 4.17% | 79,834 | - |
| 477 | NNVC | NanoViricides, Inc. | 27.55M | 5.19% | 448,204 | - |
| 478 | RNXT | RenovoRx, Inc. | 27.48M | -23.03% | 1,413,494 | 928.00K |
| 479 | RLYB | Rallybio Corporation | 27.04M | -2.41% | 135,784 | 674.00K |
| 480 | DARE | Daré Bioscience, Inc. | 26.58M | -1.59% | 67,974 | -57.13K |
| 481 | NXTC | NextCure, Inc. | 26.48M | -3.07% | 31,008 | - |
| 482 | QTTB | Q32 Bio Inc. | 26.35M | -2.26% | 35,799 | - |
| 483 | INTS | Intensity Therapeutics, Inc. | 26.31M | -8.39% | 2,218,562 | - |
| 484 | CLGN | CollPlant Biotechnologies Ltd. | 25.11M | -0.25% | 5,265 | 2.40M |
| 485 | NRXS | NeurAxis, Inc. | 24.93M | -0.43% | 50,294 | 3.36M |
| 486 | NRSN | NeuroSense Therapeutics Ltd. | 24.61M | 7.11% | 133,898 | - |
| 487 | LNAI | Lunai Bioworks Inc. | 24.57M | 2.91% | 609,653 | - |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 24.10M | -0.34% | 16,621 | - |
| 489 | ENLV | Enlivex Therapeutics Ltd. | 24.08M | 0.12% | 104,870 | - |
| 490 | APVO | Aptevo Therapeutics Inc. | 23.76M | -2.76% | 710,238 | - |
| 491 | XCUR | Exicure, Inc. | 23.65M | 1.62% | 4,688 | 500.00K |
| 492 | LEXX | Lexaria Bioscience Corp. | 23.58M | -3.64% | 166,397 | 615.92K |
| 493 | IBIO | iBio, Inc. | 23.50M | 0.87% | 821,841 | 500.00K |
| 494 | GDTC | CytoMed Therapeutics Limited | 22.62M | 4.17% | 8,594 | 573.19K |
| 495 | ITRM | Iterum Therapeutics plc | 22.59M | -16.11% | 2,613,230 | 390.00K |
| 496 | MBRX | Moleculin Biotech, Inc. | 21.47M | -4.43% | 1,299,602 | - |
| 497 | PMN | ProMIS Neurosciences, Inc. | 20.96M | -0.18% | 499,431 | - |
| 498 | CLSD | Clearside Biomedical, Inc. | 19.99M | 3.52% | 44,089 | 4.17M |
| 499 | SYBX | Synlogic, Inc. | 19.65M | 0.60% | 35,164 | 8.00K |
| 500 | CING | Cingulate Inc. | 19.57M | 4.80% | 225,298 | - |
| 501 | CASI | CASI Pharmaceuticals, Inc. | 19.52M | -5.62% | 20,592 | 31.56M |
| 502 | LIXT | Lixte Biotechnology Holdings, Inc. | 19.11M | -2.09% | 35,127 | - |
| 503 | FBLG | FibroBiologics, Inc. | 18.93M | 9.59% | 792,049 | - |
| 504 | AKTX | Akari Therapeutics, Plc | 18.90M | 1.67% | 206,251 | - |
| 505 | LSTA | Lisata Therapeutics, Inc. | 18.70M | 2.42% | 27,108 | 1.07M |
| 506 | CTXR | Citius Pharmaceuticals, Inc. | 18.08M | -3.07% | 451,873 | - |
| 507 | ATHA | Athira Pharma, Inc. | 17.83M | -3.73% | 5,224 | - |
| 508 | BCTX | BriaCell Therapeutics Corp. | 17.37M | -5.90% | 38,792 | - |
| 509 | KAPA | Kairos Pharma, Ltd. | 17.20M | 4.85% | 428,082 | - |
| 510 | PULM | Pulmatrix, Inc. | 17.20M | -3.50% | 5,210 | 3.00K |
| 511 | CRIS | Curis, Inc. | 17.20M | 17.70% | 129,906 | 11.65M |
| 512 | ALLR | Allarity Therapeutics, Inc. | 17.14M | -0.84% | 200,275 | - |
| 513 | PCSA | Processa Pharmaceuticals, Inc. | 16.99M | 2.70% | 1,104,367 | - |
| 514 | MTVA | MetaVia Inc. | 16.93M | 5.95% | 198,894 | - |
| 515 | LPCN | Lipocine Inc. | 15.93M | 1.77% | 26,018 | 4.32M |
| 516 | NCEL | NewcelX Ltd. | 15.91M | 1.75% | 31,993 | - |
| 517 | CANF | Can-Fite BioPharma Ltd. | 15.85M | -0.32% | 147,996 | 560.00K |
| 518 | HOTH | Hoth Therapeutics, Inc. | 15.78M | 0.85% | 130,231 | - |
| 519 | TRAW | Traws Pharma, Inc. | 15.46M | 22.60% | 8,122,087 | 2.85M |
| 520 | BLRX | BioLineRx Ltd. | 15.39M | -6.92% | 31,303 | 17.25M |
| 521 | ABP | Abpro Holdings, Inc. | 14.64M | -6.79% | 31,520 | 183.00K |
| 522 | LGVN | Longeveron Inc. | 14.54M | -1.17% | 223,122 | 1.44M |
| 523 | SNGX | Soligenix, Inc. | 13.82M | -0.72% | 90,636 | 2.34K |
| 524 | CMMB | Chemomab Therapeutics Ltd. | 13.76M | 4.31% | 97,550 | - |
| 525 | COCP | Cocrystal Pharma, Inc. | 13.43M | - | 39,005 | - |
| 526 | GOVX | GeoVax Labs, Inc. | 13.40M | -3.82% | 558,441 | 3.35M |
| 527 | BCDA | BioCardia, Inc. | 13.05M | -1.59% | 60,125 | 3.00K |
| 528 | ICU | SeaStar Medical Holding Corporation | 12.96M | -17.39% | 1,909,817 | 881.00K |
| 529 | DWTX | Dogwood Therapeutics, Inc. | 12.77M | 2.01% | 19,327 | - |
| 530 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.61M | 12.00% | 178,805 | - |
| 531 | VYNE | VYNE Therapeutics Inc. | 12.46M | 1.38% | 1,559,942 | 524.00K |
| 532 | EDSA | Edesa Biotech, Inc. | 12.28M | 0.87% | 43,578 | - |
| 533 | MRKR | Marker Therapeutics, Inc. | 11.94M | 3.48% | 222,035 | 4.69M |
| 534 | ERNA | Ernexa Therapeutics Inc. | 11.93M | -3.18% | 43,302 | 1,000.00 |
| 535 | BRTX | BioRestorative Therapies, Inc. | 11.51M | 6.40% | 32,688 | 383.40K |
| 536 | BIVI | BioVie Inc. | 11.31M | 0.67% | 33,307 | - |
| 537 | NEUP | Neuphoria Therapeutics Inc. | 11.29M | 0.84% | 333,000 | 15.65M |
| 538 | IMRN | Immuron Limited | 11.29M | 1.28% | 31,511 | 4.78M |
| 539 | APM | Aptorum Group Limited | 11.24M | -2.82% | 38,390 | - |
| 540 | OSRH | OSR Holdings, Inc. | 11.12M | -8.83% | 479,469 | -90.52K |
| 541 | EVGN | Evogene Ltd. | 10.79M | 1.68% | 64,412 | 9.44M |
| 542 | ADXN | Addex Therapeutics Ltd | 10.64M | -1.51% | 3,193 | 210.35K |
| 543 | IMNN | Imunon, Inc. | 10.64M | 1.44% | 47,581 | - |
| 544 | AEON | AEON Biopharma, Inc. | 10.53M | -3.77% | 150,017 | - |
| 545 | SNSE | Sensei Biotherapeutics, Inc. | 10.10M | -11.25% | 22,964 | - |
| 546 | PHGE | BiomX Inc. | 9.99M | 7.46% | 1,581,400 | - |
| 547 | PPCB | Propanc Biopharma, Inc. | 9.95M | -2.69% | 106,696 | - |
| 548 | CLRB | Cellectar Biosciences, Inc. | 9.26M | 1.05% | 67,158 | - |
| 549 | TOVX | Theriva Biologics, Inc. | 9.15M | -1.35% | 1,605,726 | - |
| 550 | XTLB | XTL Biopharmaceuticals Ltd. | 9.02M | -2.28% | 70,385 | 451.00K |
| 551 | PLRZ | Polyrizon Ltd. | 9.02M | -1.12% | 113,183 | - |
| 552 | MBIO | Mustang Bio, Inc. | 8.83M | 0.83% | 89,681 | - |
| 553 | BOLT | Bolt Biotherapeutics, Inc. | 8.77M | -2.77% | 135,798 | 4.17M |
| 554 | ALZN | Alzamend Neuro, Inc. | 8.44M | -4.72% | 57,385 | - |
| 555 | CELZ | Creative Medical Technology Holdings, Inc. | 8.11M | 11.70% | 182,443 | 6.00K |
| 556 | KPRX | Kiora Pharmaceuticals, Inc. | 7.92M | -1.14% | 48,909 | 20.00K |
| 557 | ADIL | Adial Pharmaceuticals, Inc. | 7.80M | 1.91% | 358,522 | - |
| 558 | RNAZ | TransCode Therapeutics, Inc. | 7.70M | 9.74% | 6,423 | - |
| 559 | PHIO | Phio Pharmaceuticals Corp. | 7.44M | -9.09% | 483,546 | - |
| 560 | INAB | IN8bio, Inc. | 7.37M | -3.05% | 43,283 | - |
| 561 | APRE | Aprea Therapeutics, Inc. | 7.05M | 1.68% | 41,751 | 488.24K |
| 562 | KZIA | Kazia Therapeutics Limited | 7.01M | -13.99% | 70,160 | 1.25M |
| 563 | ACXP | Acurx Pharmaceuticals, Inc. | 7.01M | -4.75% | 67,033 | - |
| 564 | MTNB | Matinas BioPharma Holdings, Inc. | 6.78M | 0.83% | 12,224 | - |
| 565 | PPBT | Purple Biotech Ltd | 6.73M | -2.95% | 186,086 | - |
| 566 | JAGX | Jaguar Health, Inc. | 6.65M | 4.71% | 55,507 | 11.81M |
| 567 | TCRT | Alaunos Therapeutics, Inc. | 6.55M | 4.21% | 35,368 | 6.00K |
| 568 | NCNA | NuCana plc | 6.51M | -2.29% | 48,570 | - |
| 569 | HCWB | HCW Biologics Inc. | 6.45M | 20.48% | 1,738,691 | 832.84K |
| 570 | LYRA | Lyra Therapeutics, Inc. | 6.33M | 0.79% | 53,308 | 600.00K |
| 571 | PTN | Palatin Technologies, Inc. | 6.33M | - | 21,966 | 350.00K |
| 572 | ENSC | Ensysce Biosciences, Inc. | 6.11M | -0.48% | 65,859 | 7.41M |
| 573 | CLDI | Calidi Biotherapeutics, Inc. | 6.04M | -1.32% | 101,263 | - |
| 574 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.01M | 0.29% | 21,412 | 15.78K |
| 575 | ENTO | Entero Therapeutics, Inc. | 5.99M | 2.72% | 51,792 | - |
| 576 | XBIO | Xenetic Biosciences, Inc. | 5.92M | 1.17% | 47,401 | 2.86M |
| 577 | GLMD | Galmed Pharmaceuticals Ltd. | 5.70M | -2.80% | 53,199 | - |
| 578 | VIVS | VivoSim Labs, Inc. | 5.66M | 1.40% | 40,227 | 140.00K |
| 579 | GNPX | Genprex, Inc. | 5.53M | 7.00% | 207,531 | - |
| 580 | SILO | Silo Pharma, Inc. | 5.50M | -5.08% | 187,630 | 72.10K |
| 581 | PMCB | PharmaCyte Biotech, Inc. | 5.35M | -0.39% | 48,411 | - |
| 582 | KTTA | Pasithea Therapeutics Corp. | 5.34M | 2.12% | 112,973 | - |
| 583 | REVB | Revelation Biosciences, Inc. | 5.33M | -1.43% | 171,741 | - |
| 584 | ASBP | Aspire Biopharma Holdings, Inc. | 5.26M | 1.05% | 546,849,252 | 1.94K |
| 585 | KALA | KALA BIO, Inc. | 4.96M | 7.31% | 278,056 | - |
| 586 | OGEN | Oragenics, Inc. | 4.67M | -1.75% | 16,330 | - |
| 587 | QLGN | Qualigen Therapeutics, Inc. | 4.63M | 7.91% | 676,211 | - |
| 588 | CYCN | Cyclerion Therapeutics, Inc. | 4.36M | -5.56% | 76,072 | 2.86M |
| 589 | GRI | GRI Bio, Inc. | 4.25M | - | 82,962 | - |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 3.96M | 6.98% | 10,202 | - |
| 591 | ELAB | PMGC Holdings Inc. | 3.94M | -3.81% | 13,778 | -605.53K |
| 592 | SPRC | SciSparc Ltd. | 3.89M | -6.25% | 23,360 | 1.31M |
| 593 | PTIX | Protagenic Therapeutics, Inc. | 3.89M | -3.33% | 23,754 | - |
| 594 | BGMS | Bio Green Med Solution, Inc. | 3.85M | -2.24% | 45,719 | 10.00K |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.74M | -22.22% | 399,061 | 1.36M |
| 596 | ONCO | Onconetix, Inc. | 3.56M | -5.33% | 27,934 | 1.22M |
| 597 | ARTL | Artelo Biosciences, Inc. | 3.54M | 2.78% | 59,438 | - |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 3.39M | 7.24% | 13,203 | 104.90K |
| 599 | GTBP | GT Biopharma, Inc. | 3.28M | 26.14% | 13,254,809 | - |
| 600 | XRTX | XORTX Therapeutics Inc. | 3.22M | -0.43% | 61,572 | - |
| 601 | SCNI | Scinai Immunotherapeutics Ltd. | 3.12M | -3.50% | 36,025 | 1.15M |
| 602 | INDP | Indaptus Therapeutics, Inc. | 2.78M | -15.20% | 39,274 | - |
| 603 | ENVB | Enveric Biosciences, Inc. | 2.74M | -3.30% | 27,512 | - |
| 604 | MLEC | Moolec Science SA | 2.31M | 0.88% | 74,432 | 7.83M |
| 605 | VRAX | Virax Biolabs Group Limited | 2.13M | 1.30% | 70,644 | 6.33K |
| 606 | DRMA | Dermata Therapeutics, Inc. | 2.09M | -2.14% | 41,472 | - |
| 607 | SLXN | Silexion Therapeutics Corp | 1.59M | -1.05% | 65,143 | - |
| 608 | PBM | Psyence Biomedical Ltd. | 1.58M | -2.87% | 27,256 | - |
| 609 | CMND | Clearmind Medicine Inc. | 1.56M | -17.62% | 9,085,250 | - |
| 610 | AZTR | Azitra, Inc. | 1.28M | 5.29% | 387,947 | 7.50K |
| 611 | SLRX | Salarius Pharmaceuticals, Inc. | 1.26M | -0.83% | 2,262,668 | - |
| 612 | CDT | CDT Equity Inc. | 853.54K | -3.46% | 18,979 | - |
| 613 | ADTX | Aditxt, Inc. | 213.14K | -11.20% | 68,654 | 12.05K |